| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 06/05/1997 | WO1997010334A3 Ribozyme therapy for the treatment and/or prevention of restenosis |
| 06/05/1997 | DE19648566A1 Isotonic lipid emulsion for parenteral application for nourishment, |
| 06/05/1997 | DE19544686A1 Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Amino acid derivatives, medicaments containing these compounds and processes for their preparation |
| 06/05/1997 | CA2309881A1 Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 06/05/1997 | CA2238762A1 2-thioxo-imidazolidin-4-one derivatives and their use for increasing hdl cholesterol concentration |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776899A1 Intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 06/04/1997 | EP0776885A1 Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses |
| 06/04/1997 | EP0776881A1 Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization |
| 06/04/1997 | EP0776660A2 Long-lasting release nifedipine preparation |
| 06/04/1997 | EP0776333A1 Peptide antagonist intermediates of neurotensin |
| 06/04/1997 | EP0776325A1 Novel use and novel derivatives of imidazole, method for preparing same, novel intermediates thus obtained, medicinal applications of same and pharmaceutical compositions containing same |
| 06/04/1997 | EP0776324A1 Endothelin antagonists |
| 06/04/1997 | EP0776323A1 Salts of an anti-migraine indole derivative |
| 06/04/1997 | EP0776213A1 Method of treating hypertension in pregnant mammals |
| 06/04/1997 | EP0776208A1 2,3-dihydro-1-(2,2,2-trifluoroethyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 06/04/1997 | EP0776203A1 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 06/04/1997 | EP0776182A1 Therapeutic use of acetazolamide for the treatment of brain edema |
| 06/04/1997 | EP0553278B1 2-phenyl-and 2-thienyl-(2)-piperidine derivatives having neuroprotective properties |
| 06/04/1997 | CN1151117A Binding of E-selectin, P-selectin or L-selectin to sialyl-Lewis(x) or sialyl-lewis(a) |
| 06/04/1997 | CN1150947A Alkenyl-benzoyl guanidine derivant |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035054C Novel isoxazolines as antiinflammatory agents |
| 06/03/1997 | US5635537 8-substituted-2-aminotetralins |
| 06/03/1997 | US5635526 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them |
| 06/03/1997 | US5635525 Benzimidazole derivatives as angiotensin II receptor antagonists, pharmacticals, and treatment of hypertension therewith |
| 06/03/1997 | US5635516 (Thia) cycloalkyl[B]indole compounds as anti-inflammatory agents |
| 06/03/1997 | US5635511 Acid addition salt derivatives; antiarrhythmia agents; active suppression of extrasystoles, ventricular flutters and fibrillations |
| 06/03/1997 | US5635507 Pharmacologically active CNS compounds |
| 06/03/1997 | US5635504 Diazepine containing dual action inhibitors |
| 06/03/1997 | US5635503 Dihydropyridine npy antagonists: piperazine derivatives |
| 06/03/1997 | US5635502 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ACE |
| 06/03/1997 | US5635215 Hydrophilic acrylic copolymer coated with cell adhesion promoter |
| 06/03/1997 | US5635187 Adding phytogenic compounds to storage solution to increase organ preservation for transplantation |
| 06/03/1997 | US5635186 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 06/03/1997 | CA2143974C Terazosin monohydrochloride and processes and intermediate for its production |
| 06/03/1997 | CA2143971C Process and intermediate for the preparation of terazosin hydrochloride dihydrate |
| 06/03/1997 | CA2134038C Potentiation of drug response |
| 05/29/1997 | WO1997019102A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | WO1997019080A1 Novel intermediates and their use to prepare n,n'-bridged bisindolylmaleimides |
| 05/29/1997 | WO1997018838A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/29/1997 | WO1997018834A1 Therapeutic fragments of von willebrand factor |
| 05/29/1997 | WO1997018824A1 Vasodilating composition |
| 05/29/1997 | WO1997018813A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2249343A1 Phosphonic acid derivatives with metallopeptidase inhibitory activity |
| 05/29/1997 | CA2238081A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2237808A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 05/28/1997 | EP0775745A2 Cathepsin G-inhibiting aptamers |
| 05/28/1997 | EP0775742A2 Inhibiting transforming growth factor beta to prevent accumulation of axtracellular matrix |
| 05/28/1997 | EP0775488A1 Stable pharmaceutical composition on the basis of acetylsalicyclic acid and tocopherol |
| 05/28/1997 | EP0775213A1 Adenovirus comprising a gene coding for glutathion peroxidase |
| 05/28/1997 | EP0775199A1 Superoxide dismutase-4 |
| 05/28/1997 | EP0775143A1 New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments |
| 05/28/1997 | EP0775141A1 Phenyl xanthine derivatives |
| 05/28/1997 | EP0775129A1 3-benzoyl benzofuran derivatives as thyroid hormone antagonists |
| 05/28/1997 | EP0775126A1 Hypolipidemic 1,4-benzothiazepine-1,1-dioxides |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0774965A1 Phenoxyphenylacetic acid derivatives |
| 05/28/1997 | EP0652884B1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity |
| 05/28/1997 | EP0641330A4 Gaba and l-glutamic acid analogs for antiseizure treatment. |
| 05/28/1997 | EP0468054B1 Benzenesulfonamide derivative |
| 05/28/1997 | CN1150804A Fibroblast growth factor-10 |
| 05/28/1997 | CN1150802A Benzoylecgonine, ecgonine and ecgonidine derivatives |
| 05/28/1997 | CN1150799A Benzoheterocyclic derivatives |
| 05/28/1997 | CN1150798A 4-carbamoyloxy-piperidine-1-carboxylic acid esters: inhibitors of cholesterol absorption |
| 05/28/1997 | CN1150589A New sulfuric acid esters of sugar alcohols |
| 05/28/1997 | CN1150542A Xueyakang medicine for external use |
| 05/28/1997 | CN1035006C Method for preparing peptide of effect having bradykinin-antagonistic agent |
| 05/28/1997 | CN1035005C Process for producing 6-(3-dimethylaminopropionyl) forskolin |
| 05/27/1997 | US5633379 3-heteroaliphatyl- and 3-hetero(aryl)aliphatyl-2(1H)-quinolone derivatives |
| 05/27/1997 | US5633344 Crosslinked polymeric ammonium salts |
| 05/27/1997 | US5633287 N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents |
| 05/27/1997 | US5633257 Phosphodiesterase inhibitor |
| 05/27/1997 | US5633251 N-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepines |
| 05/27/1997 | US5633246 Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/27/1997 | US5633240 Parenteral solutions containing metolazone |
| 05/27/1997 | US5633239 Substituted benzenesulfonylureas and -thioureas, processes for their preparation, their use for the production of pharmaceutical preparations, and medicaments containing them |
| 05/27/1997 | US5633149 Polynucleotide encoding novel chemokine expressed in inflamed adenoid |
| 05/27/1997 | US5632981 Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same |
| 05/24/1997 | CA2190801A1 Leukotriene antagonistic benzoic acid derivatives |
| 05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | WO1997018223A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | WO1997017980A1 Treatment of cardiomyopathy by removal of autoantibodies |
| 05/22/1997 | WO1997017969A1 Dihydropyrimidines and uses thereof |
| 05/22/1997 | WO1997005241A3 Methods and compositions for identifying morphogen analogs |
| 05/22/1997 | CA2237774A1 Dihydropyrimidines and uses thereof |
| 05/22/1997 | CA2237565A1 Improved method and agents for inhibiting protein aging |
| 05/22/1997 | CA2237528A1 Chimeric oligomers having an rna-cleavage activity |
| 05/21/1997 | EP0774459A1 Sulfonylamino-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent as well as medicament containing them |
| 05/21/1997 | EP0774458A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774457A1 Substituted benzodicarboxylic acid diguanidines, process for their preparation, and their use as medicament or diagnostic agent |
| 05/21/1997 | EP0774259A1 New use of organic compounds |
| 05/21/1997 | EP0774257A2 Use of piperazine and homopiperazine compounds for the inhibition of cellular adhesion and infiltration |
| 05/21/1997 | EP0773965A2 Gas phase production of polydienes |
| 05/21/1997 | EP0773964A1 Gas phase production of polydienes |
| 05/21/1997 | EP0773963A1 Gas phase polymerization process |
| 05/21/1997 | EP0773959A1 Adrenergic receptor |
| 05/21/1997 | EP0773942A1 4-indole derivatives as serotonin agonists and antagonists |
| 05/21/1997 | EP0773931A1 Quinoline derivatives as leukotriene antagonists |
| 05/21/1997 | EP0773927A2 Benzoylguanidine derivatives as medicaments |